Australia's most trusted
source of pharma news
Tuesday, 04 August 2026
Posted 4 August 2026 AM
Arrotex has announced the appointment of its first Chief Medical Officer, luring Dr Melinda Munns away from BMS to start the role from 17 August.
Munns will lead Arrotex's medical function, supporting the company's commitment to improving access to medicines and delivering better health outcomes for Australian patients.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.